| 2023/04/17 17:35:43 | |
|---|---|
| Price | |
| 45.21 CHF | |
| Difference | 0.02% (0.01) |
General attributes
| ISIN | DK0060336014 |
| Symbol | NSIS B |
| Exchange | SIX Swiss Exchange |
| Currency | CHF |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 21,444 EUR |
| Benchmark | OMX COPENHAGEN 20 |
Market data
| Bid (Bid size) | 45.21 CHF (2) |
| Ask (Ask size) | 275.30 CHF (200) |
| Open | 45.21 CHF |
| High | 45.21 CHF |
| Low | 45.21 CHF |
| Close (prev. day) | 45.20 CHF |
| VWAP | 56.36 CHF |
| Volume (pcs) | - |
| Trading volume | - |
| Number of trades | 1 |
| Last size | - |
Futures and Options
| Related Futures | 18 |
| Related Options | - |
PDF Downloads
| Company report: NOVONESIS A/S SER. B |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2023/04/17 17:35:43 | |
|---|---|
| Price | |
| 45.21 CHF | |
| Difference | 0.02% (0.01) |
General attributes
| ISIN | DK0060336014 |
| Symbol | NSIS B |
| Exchange | SIX Swiss Exchange |
| Currency | CHF |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 21,444 EUR |
| Benchmark | OMX COPENHAGEN 20 |
Market data
| Bid (Bid size) | 45.21 CHF (2) |
| Ask (Ask size) | 275.30 CHF (200) |
| Open | 45.21 CHF |
| High | 45.21 CHF |
| Low | 45.21 CHF |
| Close (prev. day) | 45.20 CHF |
| VWAP | 56.36 CHF |
| Volume (pcs) | - |
| Trading volume | - |
| Number of trades | 1 |
| Last size | - |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | - | - | - |
| Perf (abs.) | - | - | - |
| Beta | 0.18 | 0.28 | 0.67 |
| Volatility | - | - | - |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 9.04 CHF (338,640) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 34.45 CHF (58,973) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 42.10 CHF (17,723) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 46.95 CHF (7,199) |
| YTD High | date | 45.21 CHF (2023/04/17) |
| YTD Low | date | 45.21 CHF (2023/04/17) |
| 52 Weeks High | date | 45.21 CHF (2023/04/17) |
| 52 Weeks Low | date | 45.21 CHF (2023/04/17) |
All listings for NOVONESIS A/S SER. B
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Vienna Stock Exchange | 2024/04/26 | 17:32 | 52.50 EUR | 0.00 | 2 |
| Tradegate | 2024/04/26 | 22:26 | 52.32 EUR | 0.12 | 20 |
| Stuttgart | 2024/04/26 | 15:46 | 52.08 EUR | 0.00 | 14 |
| SIX Swiss Exchange | 2023/04/17 | 17:35 | 45.21 CHF | 0.00 | 1 |
| Nasdaq Copenhagen | 2024/04/26 | 16:59 | 389.60 DKK | 179.01 | 2,952 |
| Munich | 2024/04/26 | 10:44 | 51.86 EUR | 0.02 | 2 |
| London Stock Exchange European Trade Reporting | 2024/04/26 | 16:55 | 390.90 DKK | 0.00 | 2 |
| Frankfurt | 2024/04/26 | 21:41 | 52.50 EUR | 0.00 | 3 |
| FINRA other OTC Issues | 2024/04/26 | 17:29 | 53.32 USD | 0.01 | 3 |
| Duesseldorf | 2024/04/26 | 19:30 | 51.98 EUR | 0.00 | 7 |
| Berlin | 2024/04/26 | 21:43 | 52.34 EUR | 0.00 | 17 |
Company Logo
Contact Details
| NOVONESIS A/S |
| - - |
| Biologiens Vej 2 - 2800 Lyngby |
| Telefon: + |
| Fax: + |
| E-mail: - |
PDF Downloads
| Company report: NOVONESIS A/S SER. B | |
Company Profile
Novonesis A/S engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. The company was founded on January 29, 2024 is headquartered in Lyngby, Denmark. |
Members of Management Board
| Ester Baiget | Chairman of Managing Board |
| Amy Byrick | Member of Executive Committee |
| Anders Lund | Member of Executive Committee |
| Claus Crone Fuglsang | Member of Executive Committee |
| Graziela Chaluppe dos Santos Malucelli | Member of Executive Committee |
| Lars Green | Member of Executive Committee |
| Morten Enggaard Rasmussen | Member of Executive Committee |
| Tina Sejersgard Fano | Member of Executive Committee |
Board of directors
| Cees de Jong | Chairman of Supervisory Board |
| Morten Otto Sommer | Member of Supervisory Board |
| Sharon James | Member of Supervisory Board |
| Anders Knudsen | Member of Supervisory Board |
| Anne Breum | Member of Supervisory Board |
| Heine Dalsgaard | Member of Supervisory Board |
| Jens Øbro | Member of Supervisory Board |
| Jesper Brandgaard | Member of Supervisory Board |
| Kasim Kutay | Member of Supervisory Board |
| Kevin Lane | Member of Supervisory Board |
| Kim Stratton | Member of Supervisory Board |
| Lise Kaae | Member of Supervisory Board |
| Preben Nielsen | Member of Supervisory Board |